Login Register Cart 0
Generic placeholder image

Current Drug Delivery

Editor-in-Chief

ISSN (Print): 1567-2018
ISSN (Online): 1875-5704

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Differential Effects of TPM, A Phosphorylated Tocopherol Mixture, and Other Tocopherol Derivatives as Excipients for Enhancing the Solubilization of Co-Enzyme Q10 as a Lipophilic Drug During Digestion of Lipid- Based Formulations

Author(s): Anna Pham, Paul D. Gavin*, Roksan Libinaki, Gisela Ramirez, Jamal T. Khan and Ben J. Boyd*

Volume 16, Issue 7, 2019

Page: [628 - 636] Pages: 9

DOI: 10.2174/1567201816666190806114022

Price: $65

conference banner
Abstract

Background: The tocopherol-based excipient, TPM, when incorporated into a medium-chain triglyceride (MCT)-based lipid formulation, has been previously shown to improve the solubilization of Coenzyme Q10 (CoQ10) during in vitro digestion which is strongly correlated with enhanced exposure in vivo.

Methods: The current study aimed to gain further understanding of the MCT + TPM co-formulation, by assessing the formulation performance under fasted and fed in vitro digestion conditions, with different drug and excipient loading levels. Natural and synthetic-derived TPM were equivalent, and with d-α- tocopherol polyethylene glycol 1000 succinate (TPGS) outperformed other derivatives in enhancing the solubilisation of CoQ10 during digestion.

Result: Fed conditions significantly improved the solubility of CoQ10 during in vitro digestion of the formulation in comparison with fasted conditions. The addition of TPM at 10% (w/w) of the total MCT + TPM provided optimal performance in terms of CoQ10 solubilization during digestion.

Conclusion: The results further highlights the potential of TPM as an additive in lipid formulations to improve the solubilization and oral bioavailability of poorly water-soluble compounds.

Keywords: TPM, phosphorylated tocopherol, poorly water-soluble drug, lipids, digestion, formulation.

« Previous Next »
Graphical Abstract

[1]
Amidon, G.L.; Lennernäs, H.; Shah, V.P.; Crison, J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res., 1995, 12(3), 413-420.
[http://dx.doi.org/10.1023/A:1016212804288] [PMID: 7617530]
[2]
Porter, C.J.; Trevaskis, N.L.; Charman, W.N. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov., 2007, 6(3), 231-248.
[http://dx.doi.org/10.1038/nrd2197] [PMID: 17330072]
[3]
Pouton, C.W. Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci., 2006, 29(3-4), 278-287.
[http://dx.doi.org/10.1016/j.ejps.2006.04.016] [PMID: 16815001]
[4]
Humberstone, A.J.; Charman, W.N. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev., 1997, 25(1), 103-128.
[http://dx.doi.org/10.1016/S0169-409X(96)00494-2]
[5]
Kossena, G.A.; Boyd, B.J.; Porter, C.J.; Charman, W.N. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. J. Pharm. Sci., 2003, 92(3), 634-648.
[http://dx.doi.org/10.1002/jps.10329] [PMID: 12587125]
[6]
Pouton, C.W. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur. J. Pharm. Sci., 2000, 11(Suppl. 2), S93-S98.
[http://dx.doi.org/10.1016/S0928-0987(00)00167-6] [PMID: 11033431]
[7]
Williams, H.D.; Sassene, P.; Kleberg, K.; Calderone, M.; Igonin, A.; Jule, E.; Vertommen, J.; Blundell, R.; Benameur, H.; Müllertz, A.; Pouton, C.W.; Porter, C.J. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations. Pharm. Res., 2013, 30(12), 3059-3076.
[http://dx.doi.org/10.1007/s11095-013-1038-z] [PMID: 23661145]
[8]
Khan, J.; Rades, T.; Boyd, B. The precipitation behavior of poorly water-soluble drugs with an emphasis on the digestion of lipid based formulations. Pharm. Res., 2016, 33(3), 548-562.
[http://dx.doi.org/10.1007/s11095-015-1829-5] [PMID: 26597939]
[9]
Pham, A.C.; Gavin, P.; Libinaki, R.; Ramirez, G.; Boyd, B.J. A new lipid excipient, phosphorylated tocopherol mixture, TPM enhances the solubilisation and oral bioavailability of poorly water soluble CoQ10 in a lipid formulation. J. Control. Release, 2017, 268, 400-406.
[http://dx.doi.org/10.1016/j.jconrel.2017.10.039] [PMID: 29097302]
[10]
Gavin, P.D.; El-Tamimy, M.; Keah, H.H.; Boyd, B.J. Tocopheryl phosphate mixture (TPM) as a novel lipid-based transdermal drug delivery carrier: formulation and evaluation. Drug Deliv. Transl. Res., 2017, 7(1), 53-65.
[http://dx.doi.org/10.1007/s13346-016-0331-x] [PMID: 27672079]
[11]
Libinaki, R.; Gavin, P.D. Changes in bioavailability of omega-3 (DHA) through alpha-Tocopheryl Phosphate Mixture (TPM) after oral administration in rats. Nutrients, 2017, 9(9), 9.
[PMID: 28930161]
[12]
Kaukonen, A.M.; Boyd, B.J.; Porter, C.J.; Charman, W.N. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharm. Res., 2004, 21(2), 245-253.
[http://dx.doi.org/10.1023/B:PHAM.0000016282.77887.1f] [PMID: 15032305]
[13]
Sek, L.; Porter, C.J.; Kaukonen, A.M.; Charman, W.N. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J. Pharm. Pharmacol., 2002, 54(1), 29-41.
[http://dx.doi.org/10.1211/0022357021771896] [PMID: 11833493]
[14]
Persson, E.M.; Gustafsson, A.S.; Carlsson, A.S.; Nilsson, R.G.; Knutson, L.; Forsell, P.; Hanisch, G.; Lennernäs, H.; Abrahamsson, B. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids. Pharm. Res., 2005, 22(12), 2141-2151.
[http://dx.doi.org/10.1007/s11095-005-8192-x] [PMID: 16247711]
[15]
López-Lluch, G.; Del Pozo-Cruz, J.; Sánchez-Cuesta, A.; Cortés-Rodríguez, A.B.; Navas, P. Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization. Nutrition, 2019, 57, 133-140.
[http://dx.doi.org/10.1016/j.nut.2018.05.020] [PMID: 30153575]
[16]
Thomas, N.; Richter, K.; Pedersen, T.B.; Holm, R.; Mullertz, A.; Rades, T. In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate. AAPS J., 2014, 16, 539.
[http://dx.doi.org/10.1208/s12248-014-9589-4]
[17]
Porter, C.J.; Kaukonen, A.M.; Boyd, B.J.; Edwards, G.A.; Charman, W.N. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm. Res., 2004, 21(8), 1405-1412.
[http://dx.doi.org/10.1023/B:PHAM.0000036914.22132.cc] [PMID: 15359575]
[18]
Nik, A.M.; Corredig, M.; Wright, A.J. Release of lipophilic molecules during in vitro digestion of soy protein-stabilized emulsions. Mol. Nutr. Food Res., 2011, 55(Suppl. 2), S278-S289.
[http://dx.doi.org/10.1002/mnfr.201000572] [PMID: 21638776]
[19]
Ashraf, U.; Chat, O.A.; Maswal, M.; Jabeen, S.; Dar, A.A. An investigation of Pluronic P123-sodium cholate mixed system: micellization, gelation and encapsulation behavior. RSC Advances, 2015, 5(102), 83608-83618.
[http://dx.doi.org/10.1039/C5RA13002F]
[20]
Arnold, Y.E.; Imanidis, G.; Kuentz, M. Study of drug concentration effects on in vitro lipolysis kinetics in medium-chain triglycerides by considering oil viscosity and surface tension. Eur. J. Pharm. Sci., 2011, 44(3), 351-358.
[http://dx.doi.org/10.1016/j.ejps.2011.08.009] [PMID: 21884787]
[21]
Nguyen, T-H.; Hanley, T.; Porter, C.J.H.; Larson, I.; Boyd, B.J. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media. J. Pharm. Pharmacol., 2010, 62(7), 844-855.
[http://dx.doi.org/10.1211/jpp.62.07.0005] [PMID: 20636872]

Rights & Permissions Print Cite
Article Metrics
37
6
1
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy